+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implant, Tissue Expander, Acellular Dermal Matrix), By Shape (Round Shape, Anatomical Shape), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • September 2023
  • Region: North America
  • Grand View Research
  • ID: 4751751
The North America breast reconstruction market size is expected to reach USD 366.2 million by 2030, registering a CAGR of 6.8% from 2023 to 2030.This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2019, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.

Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market.

Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.

The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.

For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.

North America Breast Reconstruction Market Report Highlights

  • In terms of product, the implants segment held the largest market share of 63.5% in 2022 in the market. However, the tissue expander segment is expected to develop with the fastest growth rate of 6.9% CAGR, during the forecast period. This can be credited to the advancement in the products within the tissue expander segment
  • Based on shape, the round shape segment held the largest share of 55.3% in 2022 in the market. However, the anatomical shape is anticipated to witness the fastest growth rate of CAGR of 6.9% during the forecast period
  • Based on end-use, the hospital segment was expected to dominate the market with a 55.3% share during 2022. However, the cosmetology clinics segment is projected to witness the highest growth rate of 7.0% CAGR during the forecast period. This can be credited to the rising number of cosmetologists in the North America region.
  • Based on the region, the U.S. dominated the market with the largest revenue share of 74.4% in 2022. This can be credited to the increase in number of breast cancer & breast reconstruction procedures within this nation

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Shape
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Shape outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. North America Breast Reconstruction Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. North America Breast Reconstruction Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. North America Breast Reconstruction Market: Product Estimates & Trend Analysis
4.1. North America Breast Reconstruction Market: Key Takeaways
4.2. North America Breast Reconstruction Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Implants
4.3.1. Implants market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Silicone breast implants
4.3.2.1. Silicone breast implants estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Saline breast implants
4.3.3.1. Saline breast implants estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Tissue Expander
4.4.1. Tissue expander market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Saline expander
4.4.2.1. Saline expander estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Air tissue expander
4.4.3.1. Air tissue expander estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Acellular Dermal Matrix
4.5.1. Acellular dermal matrix market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. North America Breast Reconstruction Market: Shape Estimates & Trend Analysis
5.1. North America Breast Reconstruction Market: Key Takeaways
5.2. North America Breast Reconstruction Market: Shape Movement & Market Share Analysis, 2022 & 2030
5.3. Round Shape
5.3.1. Round shape market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Anatomical Shape
5.4.1. Anatomical shape market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. North America Breast Reconstruction Market: End Use Estimates & Trend Analysis
6.1. North America Breast Reconstruction Market: Key Takeaways
6.2. North America Breast Reconstruction Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Cosmetology Clinics
6.4.1. Cosmetology clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. North America Breast Reconstruction Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. North America Breast Reconstruction Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Mentor Worldwide LLC
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. AbbVie Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Integra LifeSciences
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Sientra, Inc.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Stryker
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Establishment Labs
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. RTI Surgical
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. MTF Biologics
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Surgical Innovation Associates
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. TELA Bio, Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America North America breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 3 North America North America breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 4 North America North America breast reconstruction market, by end use, 2018 - 2030 (USD Million)
Table 5 North America North America breast reconstruction market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 8 U.S. breast reconstruction market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada breast reconstruction market, by product, 2018 - 2030 (USD Million)
Table 10 Canada breast reconstruction market, by shape, 2018 - 2030 (USD Million)
Table 11 Canada breast reconstruction market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 North America breast reconstruction: Market outlook
Fig. 8 North America breast reconstruction: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 North America breast reconstruction market driver impact
Fig. 14 North America breast reconstruction market restraint impact
Fig. 15 North America breast reconstruction market strategic initiatives analysis
Fig. 16 North America breast reconstruction market: Product movement analysis
Fig. 17 North America breast reconstruction market: Product outlook and key takeaways
Fig. 18 Implants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Silicone breast implants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Saline breast implants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Saline expander market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Air tissue expander market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Acellular dermal matrix market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 North America breast reconstruction market: Shape movement analysis
Fig. 26 North America breast reconstruction market: Shape mode outlook and key takeaways
Fig. 27 Round shape market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Anatomical shape market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 North America breast reconstruction market: End use movement analysis
Fig. 30 North America breast reconstruction market: End use outlook and key takeaways
Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Cosmetology clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 North America breast reconstruction market: Regional movement analysis
Fig. 35 North America breast reconstruction market: Regional outlook and key takeaways
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Mentor Worldwide LLC
  • AbbVie Inc.
  • Integra LifeSciences
  • Sientra, Inc.
  • Stryker
  • Establishment Labs
  • RTI Surgical
  • MTF Biologics
  • Surgical Innovation Associates
  • TELA Bio, Inc.

Methodology

Loading
LOADING...

Table Information